Form 4: Fulgent Genetics CEO Reports RSU Tax Withholdings

Fulgent Genetics CEO Ming Hsieh reported the disposition of shares to cover tax obligations related to restricted stock unit vestings.

Summary

• CEO Ming Hsieh reported two dispositions of Fulgent Genetics, Inc. common stock.
• On February 26, 2026, 2,949 shares were disposed of at $24.76 per share.
• On March 1, 2026, 17,566 shares were disposed of at $15.33 per share.
• These dispositions were 'F' transactions, indicating shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs).
• The RSUs were granted on February 26, 2024, and February 25, 2025, respectively.
• Following these transactions, Mr. Hsieh directly beneficially owns 900,634 shares.
• Indirect beneficial ownership includes 7,895,115 shares via the Dynasty Trust, 220,816 shares via The Ming Hsieh Trust, 1,000 shares via a Uniform Transfer to Minor Account, and 1,000 shares by an immediate family member.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports routine, mandatory tax-related transactions for an executive's equity compensation and does not indicate any change in company fundamentals or strategic direction.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings detailing tax-related dispositions of restricted stock units are routine disclosures for executives and insiders, reflecting standard compensation practices rather than strategic shifts or market-moving events. These transactions are common across all industries for publicly traded companies.

Comparison to Industry Standards

• These are standard tax-related transactions for RSU vesting, common across all industries and companies that use equity compensation. There are no specific comparable companies or projects to detail as this is a personal transaction for tax purposes.

Related Party Transactions

• Securities are held by the Dynasty Trust, where Mr. Hsieh is the grantor and serves on the investment committee with his spouse and Jian Xie.
• Securities are held by The Ming Hsieh Trust, where Mr. Hsieh is the trustee and possesses sole voting and dispositive power.
• Shares are held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses sole voting and dispositive power.
• Shares are held by an immediate family member residing in the same household as Ming Hsieh.

Stakeholder Impact

• Shareholders: The transactions represent a minor reduction in the CEO's direct beneficial ownership due to tax obligations, which is a routine event and generally has minimal impact on overall shareholder value or perception.
• Employees: No direct impact on employees is indicated.
• Customers: No direct impact on customers is indicated.
• Suppliers: No direct impact on suppliers is indicated.
• Creditors: No direct impact on creditors is indicated.

Key Dates

Recommendation

This Form 4 filing details routine tax-related dispositions of shares by the CEO upon RSU vesting. Such transactions are mandatory and do not reflect a discretionary sale or a change in the company's fundamental outlook. Therefore, it provides no new information that would warrant a change in an investor's existing position, leading to a 'hold' recommendation.

Keywords

Fulgent Genetics, FLGT, Ming Hsieh, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Beneficial Ownership